Characterization of cerebral malaria in the outbred Swiss Webster mouse infected by Plasmodium berghei ANKA

International Journal of Experimental Pathology

Volumn 90, Issue 2, 2009, Pages 119-130

  Martins, Yuri Chaves ^a   Smith, Mary Jane ^a   Pelajo Machado, Marcelo ^a   Werneck, Guilherme Loureiro ^a   Lenzi, Henrique Leonel ^a   Daniel Ribeiro, Claudio Tadeu ^a   Carvalho, Leonardo José De Moura ^a,b  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b LA JOLLA BIOENGINEERING INSTITUTE   (United States)

Author keywords

Cerebral malaria; Histopathology; Murine models; Plasmodium berghei ANKA; Swiss Webster

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN EDEMA; BRAIN HEMORRHAGE; BRAIN MALARIA; CONTROLLED STUDY; DISEASE COURSE; EXPERIMENTAL MODEL; FEMALE; HISTOPATHOLOGY; INBRED STRAIN; INFECTION RISK; INFECTION SENSITIVITY; LIVER DISEASE; LUNG DISEASE; MONONUCLEAR CELL; MOUSE; NONHUMAN; OUTBRED STRAIN; PARASITEMIA; PLASMODIUM BERGHEI; PLASMODIUM BERGHEI INFECTION; PRIORITY JOURNAL; SPLEEN DISEASE; STRAIN DIFFERENCE; SWISS WEBSTER MOUSE; THYMUS DISEASE;

ANIMALS; BRAIN; DISEASE MODELS, ANIMAL; DISEASE SUSCEPTIBILITY; FEMALE; LIVER; MALARIA, CEREBRAL; MICE; MICE, INBRED CBA; PARASITEMIA; PLASMODIUM BERGHEI; SPLEEN; SURVIVAL ANALYSIS; THYMUS GLAND; VIRULENCE;

EID: 62749182782     PISSN: 09599673     EISSN: 13652613     Source Type: Journal    
DOI: 10.1111/j.1365-2613.2008.00622.x     Document Type: Article

References (67)

1. Ahsan T., Rab S.M., Shekhani M.S. (1993) Falciparum malaria or fulminant hepatic failure? J. Pak. Med. Assoc. 43, 206 208.
2. Amante F.H., Stanley A.C., Randall L.M. et al. (2007) A role for natural regulatory T cells in the pathogenesis of experimental cerebral malaria. Am. J. Pathol. 171, 548 559.
3. Anand A.C., Ramji C., Narula A.S., Singh W. (1992) Malarial hepatitis: a heterogeneous syndrome? Natl. Med. J. India 5, 59 62.
4. Bagot S., Campino S., Penha-Goncalves C., Pied S., Cazenave P.A., Holmberg D. (2002a) Identification of two cerebral malaria resistance loci using an inbred wild-derived mouse strain. Proc. Natl. Acad. Sci. U.S.A. 99, 9919 9923.
5. Bagot S., Idrissa Boubou M., Campino S. et al. (2002b) Susceptibility to experimental cerebral malaria induced by Plasmodium berghei ANKA in inbred mouse strains recently derived from wild stock. Infect. Immun. 70, 2049 2056.
6. Bennett T.N., Patel J., Ferdig M.T., Roepe P.D. (2007) Plasmodium falciparum Na+/H+ exchanger activity and quinine resistance. Mol. Biochem. Parasitol. 153, 48 58.
7. Bhalla A., Suri V., Singh V. (2006) Malarial hepatopathy. J. Postgrad. Med. 52, 315 320.
8. Bland J.M. Altman D.G. (2004) The logrank test. BMJ 328, 1073.
9. Campino S., Bagot S., Bergman M.L. et al. (2005) Genetic control of parasite clearance leads to resistance to Plasmodium berghei ANKA infection and confers immunity. Genes Immun. 6, 416 421.
10. Carvalho L.J., Lenzi H.L., Pelajo-Machado M., Oliveira D.N., Daniel-Ribeiro C.T., Ferreira-da-Cruz M.F. (2000) Plasmodium berghei: cerebral malaria in CBA mice is not clearly related to plasma TNF levels or intensity of histopathological changes. Exp. Parasitol. 95, 1 7.
11. Carvalho L.J., Ferreira-da-cruz M.F., Daniel-Ribeiro C.T., Pelajo-Machado M., Lenzi H.L. (2006) Plasmodium berghei ANKA infection induces thymocyte apoptosis and thymocyte depletion in CBA mice. Mem. Inst. Oswaldo Cruz 101, 523 528.
12. Carvalho L.J., Ferreira-da-Cruz M.F., Daniel-Ribeiro C.T., Pelajo-Machado M., Lenzi H.L. (2007) Germinal center architecture disturbance during Plasmodium berghei ANKA infection in CBA mice. Malar. J. 6, 59.
13. Chia R., Achilli F., Festing M.F., Fisher E.M. (2005) The origins and uses of mouse outbred stocks. Nat. Genet. 37, 1181 1186.
14. Clark I.A. Cowden W.B. (2003) The pathophysiology of falciparum malaria. Pharmacol. Ther. 99, 221 260.
15. Clark I.A. Rockett K.A. (1994) The cytokine theory of human cerebral malaria. Parasitol. Today 10, 410 412.
16. De-Oliveira A.C., Da-Matta A.C., Paumgartten F.J. (2006) Plasmodium berghei (ANKA): infection induces CYP2A5 and 2E1 while depressing other CYP isoforms in the mouse liver. Exp. Parasitol. 113, 256 261.
17. Eling W., van Zon A., Jerusalem C. (1977) The course of a Plasmodium berghei infection in six different mouse strains. Z. Parasitenkd. 54, 29 45.
18. Ferdig M.T., Cooper R.A., Mu J. et al. (2004) Dissecting the loci of low-level quinine resistance in malaria parasites. Mol. Microbiol. 52, 985 997.
19. Flint J., Valdar W., Shifman S., Mott R. (2005) Strategies for mapping and cloning quantitative trait genes in rodents. Nat. Rev. Genet. 6, 271 286.
20. Fortin A., Belouchi A., Tam M.F. et al. (1997) Genetic control of blood parasitaemia in mouse malaria maps to chromosome 8. Nat. Genet. 17, 382 383.
21. Fortin A., Stevenson M.M., Gros P. (2002) Complex genetic control of susceptibility to malaria in mice. Genes Immun. 3, 177 186.
22. Franke-Fayard B., Janse C.J., Cunha-Rodrigues M. et al. (2005) Murine malaria parasite sequestration: CD36 is the major receptor, but cerebral pathology is unlinked to sequestration. Proc. Natl Acad. Sci. U.S.A. 102, 11468 11473.
23. Golenser J., Domb A., Teomim D. et al. (1997) The treatment of animal models of malaria with iron chelators by use of a novel polymeric device for slow drug release. J. Pharmacol. Exp. Ther. 281, 1127 1135.
24. Good M.F., Xu H., Wykes M., Engwerda C.R. (2005) Development and regulation of cell-mediated immune responses to the blood stages of malaria: implications for vaccine research. Annu. Rev. Immunol. 23, 69 99.
25. Gramaglia I., Sobolewski P., Meays D. et al. (2006) Low nitric oxide bioavailability contributes to the genesis of experimental cerebral malaria. Nat. Med. 12, 1417 1422.
26. Grau G.E., Piguet P.F., Engers H.D., Louis J.A., Vassalli P., Lambert P.H. (1986) L3T4+ T lymphocytes play a major role in the pathogenesis of murine cerebral malaria. J. Immunol. 137, 2348 2354.
27. Guha M., Kumar S., Choubey V., Maity P., Bandyopadhyay U. (2006) Apoptosis in liver during malaria: role of oxidative stress and implication of mitochondrial pathway. FASEB J. 20, 1224 1226.
28. Gupta N., Sehgal R., Mahajan R.C., Banerjee A.K., Ganguly N.K. (1988) Role of immune complexes in cerebral malaria. Pathology 20, 373 376.
29. Hearn J., Rayment N., Landon D.N., Katz D.R., de Souza J.B. (2000) Immunopathology of cerebral malaria: morphological evidence of parasite sequestration in murine brain microvasculature. Infect. Immun. 68, 5364 5376.
30. Hermsen C., van de Wiel T., Mommers E., Sauerwein R., Eling W. (1997) Depletion of CD4+ or CD8+ T-cells prevents Plasmodium berghei induced cerebral malaria in end-stage disease. Parasitology 114 (Pt 1 7 12.
31. Hernandez-Valladares M., Naessens J., Gibson J.P. et al. (2004a) Confirmation and dissection of QTL controlling resistance to malaria in mice. Mamm. Genome 15, 390 398.
32. Hernandez-Valladares M., Rihet P., ole-MoiYoi O.K., Iraqi F.A. (2004b) Mapping of a new quantitative trait locus for resistance to malaria in mice by a comparative mapping approach with human Chromosome 5q31-q33. Immunogenetics 56, 115 117.
33. van der Heyde H.C., Nolan J., Combes V., Gramaglia I., Grau G.E. (2006) A unified hypothesis for the genesis of cerebral malaria: sequestration, inflammation and hemostasis leading to microcirculatory dysfunction. Trends Parasitol. 22, 503 508.
34. Hunt N.H. Grau G.E. (2003) Cytokines: accelerators and brakes in the pathogenesis of cerebral malaria. Trends Immunol. 24, 491 499.
35. Jerusalem C., Polder T., Wijers-Rouw M. et al. (1983) Comparative clinical and experimental study on the pathogenesis of cerebral malaria. Contrib. Microbiol. Immunol. 7, 130 138.
36. Kaul D.K., Nagel R.L., Llena J.F., Shear H.L. (1994) Cerebral malaria in mice: demonstration of cytoadherence of infected red blood cells and microrheologic correlates. Am. J. Trop. Med. Hyg. 50, 512 521.
37. Kochar D.K., Agarwal P., Kochar S.K. et al. (2003) Hepatocyte dysfunction and hepatic encephalopathy in Plasmodium falciparum malaria. QJM 96, 505 512.
38. de Kossodo S. Grau G.E. (1993) Profiles of cytokine production in relation with susceptibility to cerebral malaria. J. Immunol. 151, 4811 4820.
39. Lennert K. (1978) Malignant Lymphoma Other Than Hodgkin's Disease. Springer-Verlag Berlin. pp 833.
40. Lou J., Donati Y.R., Juillard P. et al. (1997) Platelets play an important role in TNF-induced microvascular endothelial cell pathology. Am. J. Pathol. 151, 1397 1405.
41. Lou J., Lucas R., Grau G.E. (2001) Pathogenesis of cerebral malaria: recent experimental data and possible applications for humans. Clin. Microbiol. Rev. 14, 810 820, table of contents.
42. Lovegrove F.E., Pena-Castillo L., Mohammad N., Liles W.C., Hughes T.R., Kain K.C. (2006) Simultaneous host and parasite expression profiling identifies tissue-specific transcriptional programs associated with susceptibility or resistance to experimental cerebral malaria. BMC Genomics 7, 295.
43. Lovegrove F.E., Gharib S.A., Patel S.N., Hawkes C.A., Kain K.C., Liles W.C. (2007) Expression microarray analysis implicates apoptosis and interferon-responsive mechanisms in susceptibility to experimental cerebral malaria. Am. J. Pathol. 171, 1894 1903.
44. Manenti G., Galbiati F., Noci S., Dragani T.A. (2003) Outbred CD-1 mice carry the susceptibility allele at the pulmonary adenoma susceptibility 1 (Pas1) locus. Carcinogenesis 24, 1143 1148.
45. McIntosh H.M. Olliaro P. (2000) Artemisinin derivatives for treating severe malaria. Cochrane Database Syst. Rev., CD000527.
46. Mishra S.K., Mohanty S., Das B.S. et al. (1992) Hepatic changes in P. falciparum malaria. Indian J. Malariol. 29, 167 171.
47. Mitchell A.J., Hansen A.M., Hee L. et al. (2005) Early cytokine production is associated with protection from murine cerebral malaria. Infect. Immun. 73, 5645 5653.
48. Molyneux M.E., Taylor T.E., Wirima J.J., Borgstein A. (1989) Clinical features and prognostic indicators in paediatric cerebral malaria: a study of 131 comatose Malawian children. Q. J. Med. 71, 441 459.
49. Neill A.L. Hunt N.H. (1992) Pathology of fatal and resolving Plasmodium berghei cerebral malaria in mice. Parasitology 105 (Pt 2 165 175.
50. Nitcheu J., Bonduelle O., Combadiere C. et al. (2003) Perforin-dependent brain-infiltrating cytotoxic CD8+ T lymphocytes mediate experimental cerebral malaria pathogenesis. J. Immunol. 170, 2221 2228.
51. Pamplona A., Ferreira A., Balla J. et al. (2007) Heme oxygenase-1 and carbon monoxide suppress the pathogenesis of experimental cerebral malaria. Nat. Med. 13, 703 710.
52. Patnaik J.K., Das B.S., Mishra S.K., Mohanty S., Satpathy S.K., Mohanty D. (1994) Vascular clogging, mononuclear cell margination, and enhanced vascular permeability in the pathogenesis of human cerebral malaria. Am. J. Trop. Med. Hyg. 51, 642 647.
53. Penet M.F., Kober F., Confort-Gouny S. et al. (2007) Magnetic resonance spectroscopy reveals an impaired brain metabolic profile in mice resistant to cerebral malaria infected with Plasmodium berghei ANKA. J. Biol. Chem. 282, 14505 14514.
54. Pongponratn E., Riganti M., Punpoowong B., Aikawa M. (1991) Microvascular sequestration of parasitized erythrocytes in human falciparum malaria: a pathological study. Am. J. Trop. Med. Hyg. 44, 168 175.
55. Postma N.S., Hermsen R.C., Crommelin D.J., Eling W.M., Zuidema J. (1999) Thiolated recombinant human tumor necrosis factor-alpha protects against Plasmodium berghei K173-induced experimental cerebral malaria in mice. Antimicrob. Agents Chemother. 43, 1027 1033.
56. Potter S.M., Mitchell A.J., Cowden W.B. et al. (2005) Phagocyte-derived reactive oxygen species do not influence the progression of murine blood-stage malaria infections. Infect. Immun. 73, 4941 4947.
57. Premaratna R., Gunatilake A.K., de Silva N.R., Tilakaratne Y., Fonseka M.M., de Silva H.J. (2001) Severe hepatic dysfunction associated with falciparum malaria. Southeast Asian J. Trop. Med. Public Health 32, 70 72.
58. Rae C., McQuillan J.A., Parekh S.B. et al. (2004) Brain gene expression, metabolism, and bioenergetics: interrelationships in murine models of cerebral and noncerebral malaria. FASEB J. 18, 499 510.
59. Rest J.R. (1982) Cerebral malaria in inbred mice. I. A new model and its pathology. Trans. R. Soc. Trop. Med. Hyg. 76, 410 415.
60. Sen S. Ferdig M. (2004) QTL analysis for discovery of genes involved in drug responses. Curr. Drug Targets Infect. Disord. 4, 53 63.
61. de Souza J.B. Riley E.M. (2002) Cerebral malaria: the contribution of studies in animal models to our understanding of immunopathogenesis. Microbes Infect. 4, 291 300.
62. Srivastava A., Khanduri A., Lakhtakia S., Pandey R., Choudhuri G. (1996) Falciparum malaria with acute liver failure. Trop. Gastroenterol. 17, 172 174.
63. Taylor W.R. White N.J. (2002) Malaria and the lung. Clin. Chest Med. 23, 457 468.
64. Urban B.C., Hien T.T., Day N.P. et al. (2005) Fatal Plasmodium falciparum malaria causes specific patterns of splenic architectural disorganization. Infect. Immun. 73, 1986 1994.
65. Van Zon A., Eling W., Jerusalem C. (1978) Histo- and immunopathology of a malaria (Plasmodium berghei) infection in mice. Isr. J. Med. Sci. 14, 659 672.
66. Wu R. Lin M. (2006) Functional mapping - how to map and study the genetic architecture of dynamic complex traits. Nat. Rev. Genet. 7, 229 237.
67. Yalcin B., Willis-Owen S.A., Fullerton J. et al. (2004) Genetic dissection of a behavioral quantitative trait locus shows that Rgs2 modulates anxiety in mice. Nat. Genet. 36, 1197 1202.